Carregant...
A framework for considering the risk-benefit trade-off in designing noninferiority trials using composite outcome approaches
When a new treatment regimen is expected to have comparable or slightly worse efficacy to that of the control regimen but has benefits in other domains such as safety and tolerability, a non-inferiority (NI) trial may be appropriate but is fraught with difficulty in justifying an acceptable NI margi...
Guardat en:
| Publicat a: | Stat Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770022/ https://ncbi.nlm.nih.gov/pubmed/33105524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.8777 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|